Cargando…

Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review

SIMPLE SUMMARY: Hepatocellular carcinoma is the fourth leading cause of cancer-related mortality worldwide and a major health problem. Overall survival is poor, with a five-year relative survival rate of 18.4% and only 2% in metastatic hepatocellular carcinoma. In 2020, the combination of atezolizum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falette Puisieux, Manon, Pellat, Anna, Assaf, Antoine, Ginestet, Claire, Brezault, Catherine, Dhooge, Marion, Soyer, Philippe, Coriat, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139863/ https://www.ncbi.nlm.nih.gov/pubmed/35625962 http://dx.doi.org/10.3390/cancers14102357

Ejemplares similares

Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma
por: Lellouche, Lisa, et al.
Publicado: (2023)

Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting
por: Falette-Puisieux, Manon, et al.
Publicado: (2023)

Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
por: Pellat, Anna, et al.
Publicado: (2021)

The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis
por: Jeridi, Dalel, et al.
Publicado: (2022)

Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
por: Rémond, M.S., et al.
Publicado: (2022)

Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020)

Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
por: Mortier, Victor, et al.
Publicado: (2022)

Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients
por: Dréanic, Johann, et al.
Publicado: (2015)

Updates on the Treatment of Pancreatic Diseases: Focus on Surgery, Electrochemotherapy and Rituximab
por: Coriat, Romain, et al.
Publicado: (2022)

Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
por: Moryoussef, Frédérick, et al.
Publicado: (2015)

The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer
por: Pellat, Anna, et al.
Publicado: (2022)

Self-expandable metal stent through the tumor to treat an intestinal obstruction due to pancreatic squamous cell carcinoma
por: Soliman, Heithem, et al.
Publicado: (2017)

Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
por: Camus, Baptiste, et al.
Publicado: (2021)

Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
por: Pellat, Anna, et al.
Publicado: (2020)

Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors
por: Dermine, Solène, et al.
Publicado: (2019)

Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract
por: Dermine, Solène, et al.
Publicado: (2018)

Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment
por: Pellat, Anna, et al.
Publicado: (2022)

Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement
por: Dermine, Solène, et al.
Publicado: (2020)

Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
por: Pellat, Anna, et al.
Publicado: (2021)

Outcomes of endoscopic mucosal resection for large superficial non-ampullary duodenal adenomas
por: Amoyel, Maxime, et al.
Publicado: (2022)

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors
por: Marchese, Ugo, et al.
Publicado: (2022)

Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021)

Results of the national organised colorectal cancer screening program with FIT in Paris
por: Pellat, Anna, et al.
Publicado: (2018)

Airborne transmission of SARS‐Cov2: What consequences for digestive endoscopy?
por: Chaussade, Stanislas, et al.
Publicado: (2023)

The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review
por: Barat, Maxime, et al.
Publicado: (2020)

Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?
por: Pellat, Anna, et al.
Publicado: (2021)

Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study
por: Morgant, Stephanie, et al.
Publicado: (2021)

Immunotherapy Updates in Advanced Hepatocellular Carcinoma
por: Singh, Amisha, et al.
Publicado: (2021)

Mechanisms of esophageal stricture after extensive endoscopic resection: a transcriptomic analysis
por: Barret, Maximilien, et al.
Publicado: (2023)

Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype
por: Bouchet, B P, et al.
Publicado: (2007)

Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study
por: Morgant, Stéphanie, et al.
Publicado: (2018)

Frontline therapy for advanced hepatocellular carcinoma: an update
por: Akce, Mehmet, et al.
Publicado: (2022)

Recent update on comprehensive therapy for advanced hepatocellular carcinoma
por: Wang, Hui, et al.
Publicado: (2021)

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics
por: Galmarini, C M, et al.
Publicado: (2003)

Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review
por: Doumbe-Mandengue, Paul, et al.
Publicado: (2022)

A new system to prevent SARS-CoV-2 and microorganism air transmission through the air circulation system of endoscopes
por: Chaussade, Stanislas, et al.
Publicado: (2022)

Endoscopic management of non-ampullary duodenal adenomas
por: Amoyel, Maxime, et al.
Publicado: (2022)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
por: Cucarull, Blanca, et al.
Publicado: (2022)

Clinical impact of routine CT esophagogram after peroral endoscopic myotomy (POEM) for esophageal motility disorders
por: Chartier, Marion, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4sr819n9absg3qk5lg7brags07